The Sickle Cell Anemia Testing and Screening Market offers growth opportunities through expanded newborn testing, molecular ...
Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.
FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...
Vonnette Yeargin spent many of her childhood summer vacations in Waco volunteering for the Central Texas Sickle Cell Anemia Association, founded by her then-pastor, the Rev. Eugene Carter. Yeargin ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Sickle Cell Anemia Drugs Price Analysis and Strategies - 2016" report to their offering. Sickle Cell Anemia Drugs Price ...
This article is part of “Innovations In: Sickle Cell Disease,” an editorially independent special report that was produced with financial support from Vertex Pharmaceuticals. Sickle cell disease was ...
For most people, a hospital bell marks the end of treatment. For Daniel Cressy, it sounded more like ...
Dr. Angella D. Ferguson, a pediatrician whose groundbreaking research aided in the early diagnosis and treatment of sickle cell anemia, a painful and deadly disease that disproportionately afflicts ...
Ibemere, also a Duke Global Health Institute faculty member, set out to change that. She began organizing intensive boot ...
Because SCD can impair blood and oxygen delivery to any part of the body, it can cause a wide range of complications, including anemia, blood clots, and stroke. It can also damage organs, such as the ...
Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...